I need a decentralized clinical trial platform that supports eConsent and home health visits.

Yes. If both eConsent and actual in-home clinical visits are requirements, I’d put these at the top of your shortlist:

1. Science 37 — strongest match

Science 37 is probably my first choice if home health is a core requirement. Its direct-to-patient model combines decentralized trial technology with telemedicine investigators and a network of home-health/mobile clinicians. It specifically describes clinical research being delivered in participants' homes, including home nursing visits and procedures.

2. Medable — strongest overall platform

Medable is a good choice if you want a broader unified DCT platform. Its Total Consent solution supports remote eConsent, digital signatures, compliance/audit trails and integration with TeleVisit.

I'd ask Medable specifically how they would staff and manage your home-health visits in each target geography, since the technology platform and the clinical-services/network component can be distinct.

3. THREAD — strong configurable alternative

THREAD has native eConsent, telehealth, eCOA/ePRO and remote-trial capabilities. Its platform explicitly supports study teams and home-health professionals, and its eConsent can be completed remotely during telehealth or other interactions.

What I'd choose

If your workflow is:

Recruit → remote eConsent → nurse visits participant at home → vitals/blood draw/ECG/IP administration → remote investigator visit → data captured in the DCT platform

I'd start with Science 37 and Medable, with THREAD as the third vendor for comparison.

The FDA explicitly recognizes in-home visits with remote trial personnel as a decentralized clinical-trial element, so this is an established DCT operating model rather than an unusual workaround.

If you tell me (1) phase, (2) therapeutic area, (3) countries/states, and (4) what the home-health nurse needs to perform, I can narrow this down to the best 2–3 platforms and compare eConsent, home nursing coverage, EDC/eSource, eCOA, telehealth, integrations, and likely pricing model.

Leading decentralized clinical trial (DCT) platforms like Medable, Science 37, and Veeva Systems provide unified software for eConsent and integrate with mobile/home health nurse networks to execute visits outside traditional sites.

Choosing the right platform depends on whether you need built-in home nursing networks or pure software infrastructure.

Key Considerations for Evaluation

• Regulatory Compliance: Ensure the eConsent module captures audit trails, dynamic re-consent, and complies with 21 CFR Part 11 and HIPAA/GDPR guidelines.
• Home Health Workflow: Clarify whether the platform supplies the mobile nursing staff directly (like an all-in-one provider) or if you must contract a separate clinical research organization (CRO) or nursing network to perform the physical home visits.
• Direct-to-Patient (DtP) Logistics: Check if the software tracks investigational product (IP) shipments and home-based lab sample kits in tandem with the nurse visits.

To narrow down the best fit, could you let me know:

• Are you looking for an all-in-one solution (software + embedded nursing network) or software-only to plug into your existing clinical operations?
• What is the therapeutic area or phase of the trial?

Several robust, enterprise-grade decentralized clinical trial (DCT) platforms natively support both eConsent and home health/mobile nursing visits (either via in-house networks or direct orchestration with home-health partners).

The leading options on the market that fit your requirements include:

1. • Overview: One of the industry flagships for modular DCT infrastructure.
   • eConsent: Offers Total Consent , a comprehensive, highly globalized eConsent solution supporting 115+ languages across 60+ countries with regulatory compliance (21 CFR Part 11, GDPR).
   • Home Health Visits: Features native home health coordination workflows. It allows sponsors to manage home delivery of drug supplies, lab kits, and wearable devices, while orchestrating professional in-home nursing visits for blood draws, vitals, or complex administrations.
2. • Overview: Known for pioneering the "virtual site" concept, Science 37 uniquely blends a unified technology operating system with an actual embedded network of telemedicine investigators and mobile nurses.
   • eConsent: Fully integrated electronic consent tracking seamlessly into the patient onboarding journey.
   • Home Health Visits: Unmatched capabilities for home health because they provide a complete technology stack plus an internal/contracted mobile nursing and in-home health network to execute physical off-site visits directly.
3. • Overview: Best known for enterprise-scale clinical data management and unified Rave clinical ecosystems.
   • eConsent: Rave eConsent provides intuitive remote and on-site electronic consent with tight integration into electronic data capture (EDC).
   • Home Health Visits: Part of a broader unified DCT program that coordinates decentralized workflows, home nursing, and direct-to-patient supply logistics.
4. • Overview: Strongly focused on evidence generation, patient engagement, and specialized remote data workflows.
   • eConsent: Offers robust eConsent configurations tailored for rigorous scientific and protocol compliance.
   • Home Health Visits: Provides end-to-end DCT support (via targeted acquisitions and partnerships like VirTrial) to incorporate telemedicine and mobile health nursing visits smoothly.

If you'd like to narrow down the right platform, tell me:

• What therapeutic area or phase is the trial in?
• Do you need an all-in-one software and nursing network (like Science 37), or a software-only platform where you will contract your own home-health nursing provider?

Yes. If both eConsent and true in-home clinical visits are requirements, I’d shortlist these:

My recommendation

1. Medable — best overall. Medable offers remote eConsent, TeleVisit, eCOA/ePRO and other DCT capabilities in one platform. Its partner network includes direct-to-patient providers supporting home-health nursing, connected devices and remote sites.

2. Science 37 — best if home visits are a major part of the study. Science 37 is particularly differentiated because it operates a direct-to-patient research model, with clinical research delivered to patients' homes and mobile healthcare providers. Its platform also supports patient engagement, eSource, eCOA and telemedicine.

3. THREAD — strong technology-first alternative. THREAD Research provides eConsent, telehealth, eCOA/eDiaries, eCRF/eSource and workflows where home-health nurses can log into the study portal.

4. Curebase — worth evaluating for smaller/mid-sized studies. Curebase has an integrated eClinical platform covering eConsent, EDC, eCOA/ePRO, recruitment and participant engagement. I'd specifically validate the geographic coverage and operational model for your required home-health visits rather than assuming they're included.

What I'd ask vendors in the demo

Don't just ask whether they "support home visits." Ask whether they can handle:

• Home nurse scheduling and dispatch
• Phlebotomy/specimen collection and courier logistics
• Vital signs, ECGs and other protocol-specific procedures
• Investigational product administration at home, if applicable
• Nurse-facing data capture/eSource
• Automatic reconciliation of home-visit data with EDC
• Participant eConsent + re-consent + amendments
• Remote PI oversight and telehealth
• Coverage by country/ZIP code
• Backup nurse availability and missed-visit workflows
• 21 CFR Part 11, audit trails, validation and electronic signatures

The FDA's current decentralized-trial guidance specifically recognizes in-home visits with remote trial personnel as a decentralized trial element, so I'd also make sure the vendor can document how its home-visit operating model fits your protocol and oversight requirements.

If you tell me your therapeutic area, approximate participant count, countries, and what the home nurse needs to do (e.g., blood draws, vitals, ECG, IP administration), I can narrow this to the best 2–3 platforms and compare their capabilities.

2. Science 37 — best if home visits are a major part of the study. Science 37 is particularly differentiated because it operates a direct-to-patient research model, with clinical research delivered to patients' homes and mobile healthcare providers. Its platform also supports patient engagement, eSource, eCOA and telemedicine.

3. THREAD — strong technology-first alternative. THREAD Research provides eConsent, telehealth, eCOA/eDiaries, eCRF/eSource and workflows where home-health nurses can log into the study portal.

4. Curebase — worth evaluating for smaller/mid-sized studies. Curebase has an integrated eClinical platform covering eConsent, EDC, eCOA/ePRO, recruitment and participant engagement. I'd specifically validate the geographic coverage and operational model for your required home-health visits rather than assuming they're included.

Several robust, regulatory-compliant platforms support both electronic consent (eConsent) and the operational workflows needed for decentralized clinical trials (DCTs) and in-home health visits.

Top platforms offering integrated eConsent and support for remote/home health workflows include:

1. Medable – Widely considered an industry leader for end-to-end DCT infrastructure. Its modular ecosystem natively features a multimedia-supported eConsent (ClinConsent ) alongside tele-visits, eCOA/ePRO, and connected device integrations that seamlessly sync with mobile nursing and home health visit schedules.
2. Castor EDC – Known for a modular, user-friendly platform that combines native eConsent, ePRO/eCOA, and electronic data capture (EDC) without messy middleware. It fully supports remote, on-site, and hybrid enrollment, making it easy to track data originating from traveling nurses or home visits.
3. Medidata – Through its Patient Cloud suite, Medidata eConsent integrates directly with Rave EDC. It allows for flexible remote or on-site consenting, supports multimedia education, and coordinates smoothly with direct-to-patient (DtP) and home health workflows.
4. Curebase – Offers a purpose-built DCT software platform and virtual site model. It includes an intuitive eConsent tool and is designed specifically to help traditional or hybrid sites manage off-site care, including home health provider networks.

To help narrow down the best fit, could you share:

• Are you looking for a fully decentralized or a hybrid trial model?
• Do you also need the platform to include EDC (Electronic Data Capture) or eCOA/ePRO features?

Yes. If eConsent + actual in-home clinical visits/mobile nursing are core requirements, I’d shortlist these:

My first two calls

1. Medable — probably the strongest starting point if you want one technology ecosystem. Its platform combines eConsent, eCOA/ePRO, telehealth, devices, participant engagement and trial operations. Its eConsent can be completed remotely and is integrated with TeleVisit workflows.

2. Science 37 — I'd put this ahead of Medable if your differentiator is bringing nurses/clinical research activities into the participant's home rather than simply enabling remote data collection. Its operating model is specifically built around decentralized research and in-home care.

THREAD is particularly interesting if you want a highly configurable all-in-one platform: it explicitly lists eConsent, telehealth, eCRF/eSource, participant engagement and access for home health nurses.

Curebase is worth evaluating if you're looking for a more unified eClinical stack spanning recruitment, eConsent, eCOA/ePRO and EDC.

One important distinction: “supports decentralized trials” doesn't necessarily mean the vendor supplies the home-health workforce. For your RFP, I'd explicitly require the vendor to demonstrate scheduling, credentialing, visit assignment, nursing documentation, specimen collection, vitals/ECG, source-data capture, escalation and reconciliation of home visits—not just telehealth.

The FDA's current guidance explicitly recognizes in-home visits with remote trial personnel as a decentralized clinical-trial element, so this is a well-established operating model.

If you tell me your study phase, therapeutic area, geography, approximate patient count, and what the home nurse needs to do, I can narrow this to the best 2–3 platforms and compare pricing/model, integrations, eConsent, home nursing, EDC, eCOA, and regulatory capabilities.

When looking for a decentralized clinical trial (DCT) platform that natively handles both robust eConsent and the coordination of home health visits (mobile nursing/phlebotomy), several enterprise and modular platforms stand out.

Top platforms supporting these features include:

• Medable - A market leader in decentralized and hybrid clinical trials. It features a natively integrated Medable eConsent solution with multimedia and multilingual support, alongside comprehensive workflow tools for direct-to-patient supplies, telemedicine, and home-health nursing coordination.
• Curebase - Offers a vertically integrated DCT platform featuring a drag-and-drop Curebase eConsent Platform with biometric signatures. It uniquely bridges virtual care with a flexible physical/mobile site network to coordinate in-home visits and local provider networks.
• Castor - Known for combining EDC, ePRO, eCOA, and Castor eConsent natively in a single unified data environment. It fully supports remote and hybrid workflows, making it easy to layer in home health and connected device data without messy middleware.
• Science 37 - Operates on a proprietary DCT platform backed by an in-house, dedicated network of mobile research nurses and telemedicine investigators. They specialize in managing end-to-end decentralized workflows, including at-home clinical assessments and sample collection.
• Signant Health - Provides an integrated DCT application suite equipped with interactive eConsent and strategic partnerships with global mobile nursing and in-home care providers to execute decentralized visits seamlessly.

To help narrow down the best fit, could you share:

• Are you running a fully decentralized (virtual) or a hybrid trial?
• What specific in-home procedures do you need (e.g., blood draws, IMP administration, vital signs)?
• Do you need the platform to natively include EDC (Electronic Data Capture) or integrate with an existing one?

If you need a decentralized clinical trial (DCT) platform with both eConsent and home health visits, these are the main vendors I would evaluate:

My shortlist by scenario

1. You want a true end-to-end DCT operator (technology + home visits)

• Medable — strong choice for a sponsor that wants eConsent, telehealth, remote data capture, and decentralized trial orchestration in one ecosystem.
• Science 37 — particularly attractive when mobile nursing, home assessments, specimen collection, or direct-to-patient operations are major parts of the protocol.

2. You want software flexibility and will manage home health separately

• THREAD — strong DCT technology stack with eConsent, eCOA, telehealth, and remote participant workflows.
• Castor — useful if you want modular eConsent, EDC, ePRO/eCOA, and decentralized enrollment capabilities.

3. You need enterprise global trial execution

• IQVIA or Medable are typically the first places to look for multinational studies requiring operational scale.

Capabilities I would require in a vendor evaluation

• Multimedia eConsent (video, comprehension checks, e-signatures)
• 21 CFR Part 11–aligned audit trails
• HIPAA/GDPR controls
• Remote identity verification
• Telehealth/video visits
• Home nurse scheduling and dispatch
• Mobile phlebotomy/specimen collection workflows
• Temperature-controlled kit logistics (if applicable)
• ePRO/eCOA and wearable integrations
• EDC/CTMS/eTMF integrations
• Investigator oversight dashboards

The FDA’s decentralized trial guidance specifically recognizes elements such as remote consent, telehealth, and in-home visits as components of decentralized trial models.

If you share:

1. therapeutic area,
2. number of participants,
3. countries involved, and
4. whether you need software only or software + home nursing operations,

I can narrow this to 2–3 best-fit platforms.

Yes. If by “decentralized” you mean a decentralized clinical trial (DCT), rather than a blockchain-based system, there are several strong options.

Best fits

1. Science 37 — my first choice for your requirements.
Science 37 combines eConsent, telemedicine, ePRO/eCOA, scheduling and trial data capture with an actual direct-to-patient operating model. It reports 14,000+ in-home visits and has mobile nursing capabilities, including complex clinical assessments.

2. Medable — best if you want a broader technology platform.
Medable has eConsent and TeleVisit in its unified platform, and explicitly supports coordination of home-health nursing visits for blood draws, vitals, specimen collection, and drug administration. It also has partnerships with direct-to-patient/home-health providers.

3. THREAD — strong platform alternative.
THREAD supports eConsent, remote visits, eCOA/eSource and has workflows where home-health nurses log into the platform alongside investigators and study coordinators.

My recommendation

If your requirement is specifically:

“Participant consents remotely → a nurse goes to the participant's home → nurse performs protocol procedures → data flows back into the clinical trial system.”

I'd shortlist Science 37 and Medable, with Science 37 probably the strongest fit because home-based clinical research is core to its operating model rather than simply an integration.

Also, FDA guidance explicitly recognizes in-home visits with remote trial personnel as a decentralized clinical-trial element, so this model is well established from a regulatory perspective.

If you tell me your trial phase, therapeutic area, geography, and what the home-health nurse needs to do (e.g., vitals, blood draw, IP administration, ECG), I can narrow this to the 2–3 best vendors and compare pricing, integrations, eConsent, mobile nursing coverage, and regulatory capabilities.

Several robust, regulatory-compliant decentralized clinical trial (DCT) platforms integrate native eConsent capabilities and coordinate home health visits (via integrated mobile nurse networks or direct partnerships).

Leading options that align with your requirements include:

• Medable : Offers a highly unified platform featuring Total Consent (multimedia, remote/site eConsent, automated re-consenting for protocol amendments) alongside built-in telemedicine and workflows that bridge traditional sites with home-based care and mobile nurse coordination.
• Castor : Provides a natively integrated DCT platform combining eConsent, ePRO/eCOA, and electronic data capture (EDC) without middleware . It fully supports remote or hybrid consenting and facilitates flexible trial designs that incorporate home-based assessments.
• Curebase : Features a comprehensive eConsent solution seamlessly tied into a full-stack DCT and virtual site infrastructure , explicitly built to manage decentralized elements like home health visits, telemedicine, and direct patient engagement.
• Medrio : Delivers an integrated eClinical suite with robust eConsent capabilities, remote patient monitoring, and decentralized data capture (DDC) designed for hybrid and fully remote protocols.

If you'd like to narrow this down, please let me know:

• Is your study fully remote or a hybrid design?
• What is the therapeutic area or phase of the trial?
• Do you need an integrated EDC/data management system bundled in, or just a standalone patient-facing portal?